Here are five recent news updates on key gastroenterology and endoscopy companies.
AbbVie announced a late-stage study found its hepatitis C treatment Viekira Pak was effective with our without compound ribavirin, according to a Reuters report.
Boston Scientific's short interest dropped 11.9 percent from May 15 to May 29, according to a report from The Legacy.
EndoGastric Solutions appointed three new members to its executive team. The new appointments include:
• Adrian Lobontiu, MD, FACS, as medical director
• Philip Macdonald as vice president of healthcare economics, policy and reimbursement
• Mike Zagger as vice president of sales and marketing
https://www.beckersasc.com/gastroenterology-and-endoscopy/endogastric-solutions-adds-3-new-executive-team-members.html
gMed held its annual group user conference, the gMed Summit, in Fort Lauderdale, Fla., on June 18 to June 20.
Valeant Pharmaceuticals and Progenics Pharmaceuticals submitted a new drug application to the FDA for RELISTOR, an oral treatment for opioid-induced constipation, according to a Nasdaq report.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.